Press Room
FREE Global Kidney Cancer Caregiver Support Tool
12/13/2012
Caregivers and family members play an important and prominent role throughout the kidney cancer treatment process. The Kidney Cancer Association is pleased to offer Lotsa Helping Hands as part of our commitment to supporting caregivers of those battling kidney cancer.
Transitional Cell Cancer: A Cancer of the Urinary System
12/13/2012
Transitional cell cancer is a cancer occurring in the urinary system, i.e., the kidneys, urinary bladder and accessory organs of the urinary system and occurs in the inner tissue lining of these hollow organs.
News from HealthIT.gov
12/11/2012
Health information technology (health IT) makes it possible for health care providers to better manage patient care through secure use and sharing of health information.
Save A Life: Donate Your Old Car
12/10/2012
Get a maximum tax deduction and join the fight against kidney cancer by donating your old vehicle to the Kidney Cancer Association.
Hemispherx's Ampligen For The Treatment Of Chronic Fatigue Syndrome: A Regulatory Conundrum
12/10/2012
Rintatolimod was first synthesized in the 1970s and has been proposed as a treatment for illnesses such as CFS, HIV, hepatitis B, hepatitis C, and cancers, including renal cell cancer...
ASCO/ASTRO/SUO GU 2013 Scientific Program Preview
12/10/2012
Meeting agenda and related materials, including abstract previews
Government forces elderly man with kidney cancer to pay for treatment
12/08/2012
Will this happen to patients living with kidney cancer under ObamaCare? Roy Dashwood, 81, who has advanced kidney cancer, will have to pay for all his treatments, test and travel, out of pocket, if he takes a new drug recommended by his oncologist.
U.S. Patent Issuance Covering HSP90 Inhibitor Debio 0932
12/07/2012
Curis, Inc. (CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the U.S. Patent and Trademark Office has issued a patent covering a genus of compounds that includes Debio 0932, an orally-administered Heat Shock Protein 90 (HSP90) inhibitor, which is being developed by Curis' licensee Debiopharm.
Six-year-old Ontario boy wins battle with cancer, has trophy to prove it
12/07/2012
Ottawa's Funhaven Family Fun Centre threw a party for 6-year-old Isaac Ciarlo and more than 100 of his family and friends to celebrate the end of the young boy's cancer treatments.
NICE gives 'thumbs down' to new kidney cancer drug
12/07/2012
NICE, the healthcare guidance body, has issued draft guidance not recommending axitinib (Inlyta, Pfizer) for the treatment of advanced kidney cancer. When IPAB convenes under ObamaCare, patients in the US should beware that their drug access may be severely limited, as is now the case in the UK.
News Feed